Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Overview of attention for article published in Cancer Immunology Research, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 3 news stories from 3 outlets.

TAMPA, Fla. — Therapeutic cancer vaccines are a growing area of immunology research.

TAMPA, Fla. Therapeutic cancer vaccines are a growing area of immunology research.

Newswise — TAMPA, Fla. — Therapeutic cancer vaccines are a growing area of immunology research.